A detailed history of Gulf International Bank (Uk) LTD transactions in Abb Vie Inc. stock. As of the latest transaction made, Gulf International Bank (Uk) LTD holds 139,084 shares of ABBV stock, worth $24.4 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares
139,084
Previous 145,191 4.21%
Holding current value
$24.4 Million
Previous $24.9 Million 10.29%
% of portfolio
0.7%
Previous 0.63%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$163.84 - $199.33 $1 Million - $1.22 Million
-6,107 Reduced 4.21%
139,084 $27.5 Million
Q2 2024

Jul 10, 2024

SELL
$154.79 - $180.76 $605,538 - $707,133
-3,912 Reduced 2.62%
145,191 $24.9 Million
Q1 2024

Apr 11, 2024

BUY
$159.82 - $182.1 $113,632 - $129,473
711 Added 0.48%
149,103 $27.2 Million
Q4 2023

Jan 11, 2024

SELL
$137.6 - $154.97 $1.81 Million - $2.04 Million
-13,174 Reduced 8.15%
148,392 $23 Million
Q3 2023

Oct 10, 2023

SELL
$133.59 - $154.65 $2.21 Million - $2.55 Million
-16,521 Reduced 9.28%
161,566 $24.1 Million
Q2 2023

Aug 02, 2023

SELL
$132.51 - $164.9 $6.95 Million - $8.64 Million
-52,424 Reduced 22.74%
178,087 $24 Million
Q1 2023

Apr 12, 2023

SELL
$144.61 - $166.54 $9.26 Million - $10.7 Million
-64,000 Reduced 21.73%
230,511 $36.7 Million
Q4 2022

Feb 08, 2023

BUY
$138.31 - $165.87 $76,070 - $91,228
550 Added 0.19%
294,511 $47.6 Million
Q3 2022

Oct 07, 2022

BUY
$134.21 - $153.93 $603,945 - $692,685
4,500 Added 1.55%
293,961 $39.5 Million
Q2 2022

Jul 19, 2022

BUY
$137.62 - $174.96 $41,286 - $52,488
300 Added 0.1%
289,461 $44.3 Million
Q1 2022

May 05, 2022

BUY
$131.98 - $163.75 $17,157 - $21,287
130 Added 0.04%
289,161 $46.9 Million
Q4 2021

Jan 24, 2022

SELL
$107.43 - $135.93 $6.45 Million - $8.16 Million
-60,017 Reduced 17.19%
289,031 $39.1 Million
Q3 2021

Nov 10, 2021

SELL
$106.4 - $120.78 $403,575 - $458,118
-3,793 Reduced 1.07%
349,048 $37.7 Million
Q2 2021

Aug 10, 2021

SELL
$105.21 - $117.21 $140,876 - $156,944
-1,339 Reduced 0.38%
352,841 $39.7 Million
Q1 2021

May 14, 2021

SELL
$102.3 - $112.62 $4.08 Million - $4.49 Million
-39,907 Reduced 10.13%
354,180 $38.3 Million
Q4 2020

Feb 12, 2021

SELL
$80.49 - $108.67 $2.25 Million - $3.04 Million
-27,953 Reduced 6.62%
394,087 $42.2 Million
Q3 2020

Oct 21, 2020

SELL
$85.91 - $100.83 $351,457 - $412,495
-4,091 Reduced 0.96%
422,040 $37 Million
Q2 2020

Jul 24, 2020

BUY
$73.37 - $98.18 $5.26 Million - $7.04 Million
71,656 Added 20.21%
426,131 $41.8 Million
Q1 2020

May 12, 2020

BUY
$64.5 - $97.79 $217,623 - $329,943
3,374 Added 0.96%
354,475 $27 Million
Q4 2019

Feb 05, 2020

SELL
$72.13 - $90.25 $82,949 - $103,787
-1,150 Reduced 0.33%
351,101 $31.1 Million
Q3 2019

Oct 08, 2019

SELL
$62.98 - $75.72 $129,171 - $155,301
-2,051 Reduced 0.58%
352,251 $26.7 Million
Q2 2019

Jul 10, 2019

SELL
$65.7 - $83.98 $106,565 - $136,215
-1,622 Reduced 0.46%
354,302 $25.8 Million
Q1 2019

Apr 18, 2019

SELL
$77.14 - $90.79 $40,961 - $48,209
-531 Reduced 0.15%
355,924 $28.7 Million
Q4 2018

Jan 08, 2019

SELL
$77.85 - $96.01 $12.1 Million - $15 Million
-155,939 Reduced 30.43%
356,455 $32.9 Million
Q3 2018

Nov 05, 2018

BUY
$88.91 - $98.84 $1.95 Million - $2.17 Million
21,919 Added 4.47%
512,394 $48.5 Million
Q2 2018

Jul 05, 2018

SELL
$89.78 - $106.23 $1.34 Million - $1.59 Million
-14,958 Reduced 2.96%
490,475 $45.4 Million
Q1 2018

May 09, 2018

BUY
$92.01 - $123.21 $85,937 - $115,078
934 Added 0.19%
505,433 $47.8 Million
Q4 2017

Jan 17, 2018

BUY
$89.56 - $98.21 $170,164 - $186,599
1,900 Added 0.38%
504,499 $48.8 Million
Q3 2017

Oct 11, 2017

BUY
$69.85 - $89.22 $35.1 Million - $44.8 Million
502,599
502,599 $44.7 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Gulf International Bank (Uk) LTD Portfolio

Follow Gulf International Bank (Uk) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gulf International Bank (Uk) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Gulf International Bank (Uk) LTD with notifications on news.